AATF and hematocrit: If manipulation of apoptosis would be possible in HT patients, as suggested to be one of therapeutic strategies for autoimmune diseases79, then these proteins, especially AATF, could be good therapeutic target candidates for testing the prevention of further thyroid damage in HT patients.